Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Doximity, Inc. Class A Common Stock
(NY:
DOCS
)
60.80
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Doximity, Inc. Class A Common Stock
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Why AirSculpt Technologies Shares Are Trading Lower By 20%; Here Are 31 Stocks Moving Premarket
November 11, 2022
Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.7% to $3.93 in pre-market trading after the company reported a $5 million share repurchase program.
Via
Benzinga
Doximity, Matterport And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 11, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Doximity, Beazer Homes And 3 Stocks To Watch Heading Into Friday
November 11, 2022
With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
8 Analysts Have This to Say About Doximity
October 24, 2022
Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:
Via
Benzinga
What 7 Analyst Ratings Have To Say About Doximity
October 13, 2022
Analysts have provided the following ratings for Doximity (NYSE:DOCS) within the last quarter:
Via
Benzinga
7 Analysts Have This to Say About Doximity
October 13, 2022
Doximity (NYSE:DOCS) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Analyst Ratings for Doximity
September 07, 2022
Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:
Via
Benzinga
Why Doximity Stock Is Soaring After Hours
November 10, 2022
Doximity Inc (NYSE: DOCS) shares are trading higher in Thursday's after-hours session after the company reported better-than-expected
Via
Benzinga
Doximity Announces Fiscal 2023 Second Quarter Financial Results
November 10, 2022
From
Doximity
Via
Business Wire
Why Shares of Doximity Dropped 12.4% in October
November 07, 2022
Investors are expecting lower Doximity revenue from advertising.
Via
The Motley Fool
2 Beaten-Down Growth Stocks You Can Confidently Buy Right Now
November 06, 2022
These fast-growing businesses have what they need to weather an economic downturn.
Via
The Motley Fool
3 Beaten-Down Growth Stocks That Could Soar 44.1% to 52.1%, According to Wall Street
October 31, 2022
The analysts who follow these fast-growing businesses think their stock prices could shoot much higher.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Upgrades
Via
Benzinga
Doximity to Release Fiscal 2023 Second Quarter Results on November 10, 2022
October 20, 2022
From
Doximity
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022
October 24, 2022
Upgrades
Via
Benzinga
Which of These Bear Market Growth Stocks Is More Likely to Bounce Back?
October 19, 2022
Both look like bargains, but only one is.
Via
The Motley Fool
3 Growth Stocks That Could Soar 62.6% to 66.3%, According to Wall Street
October 18, 2022
Find out why analysts have such high hopes for these top growth stocks.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
October 13, 2022
Upgrades
Via
Benzinga
Why Now Is the Time to Buy Telehealth Stocks
October 13, 2022
Stocks in this beaten-down industry possess exciting growth opportunities in the long run.
Via
The Motley Fool
Why Norwegian Cruise Line Shares Climbed By Around 12%; Here Are 66 Biggest Movers From Yesterday
October 13, 2022
Gainers Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058 on Wednesday.
Via
Benzinga
Cameco, Kinnate Biopharma And Other Big Losers From Wednesday
October 13, 2022
U.S. stocks closed slightly lower on Wednesday. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Why T2 Biosystems Shares Are Trading Lower By Over 28%, Here Are 41 Stocks Moving In Wednesday's Mid-Day Session
October 12, 2022
Gainers Code Chain New Continent Limited (NYSE: CCNC) shares jumped 74% to $0.2868 after declining around 14% on Tuesday.
Via
Benzinga
2 High-Conviction Growth Stocks Down 51.4% and 70.9% to Buy Now and Hold Forever
October 10, 2022
The road ahead of these fast-growing businesses is in better shape than their stock prices would suggest.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
September 16, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
September 07, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 26, 2022
Via
Benzinga
Micron Technology, Novavax, CarGurus And Some Other Big Losers From Tuesday
August 10, 2022
U.S. stocks closed lower, with the Nasdaq dropping 150 points on Tuesday. Here is the list of some big stocks moving lower in the previous session.
Via
Benzinga
GameStop, Signify Health And Some Other Big Gainers From Monday
August 09, 2022
U.S. stocks closed mixed on Monday. Here is the list of some big stocks moving higher in the previous session.
Via
Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
August 10, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Via
Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
August 09, 2022
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....
Via
Benzinga
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.